TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation

被引:96
|
作者
Doedens, JR [1 ]
Mahimkar, RM [1 ]
Black, RA [1 ]
机构
[1] Amgen Inc, Dept Cell Biol, Seattle, WA 98101 USA
关键词
ectodomain shedding; metalloprotease; disintegrin; TACE; ADAM; TNF;
D O I
10.1016/S0006-291X(03)01381-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor necrosis factor-alpha converting enzyme (TACE/ADAM-17) is a metalloprotease disintegrin that cleaves a variety of membrane proteins, releasing ("shedding") their extracellular domains from cells. Most TACE-mediated shedding events occur at low basal rates that are enhanced by treatment of cells with a variety of stimuli. To study the mechanism of induced shedding, we developed a peptide-cleavage assay that measures the cellular TACE activity. In unstimulated cells, cleavage of a TNFalpha processing-site peptide was mediated mainly by enzymes other than TACE. However, stimulation of cells with phorbol-12-myristate-13-acetate (PMA) increased peptide cleavage in a TACE-dependent manner. PMA treatment did not increase the amount of TACE on the cell surface. Moreover, the cytoplasmic domain of TACE was not required for the induced activity. Based on these observations, induction of TACE-mediated shedding events occurs at least in part via an increase in the enzymatic activity of cellular TACE, independent of its cytoplasmic domain. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 50 条
  • [41] Reactive Oxygen Species and p38 Mitogen-activated Protein Kinase Mediate Tumor Necrosis Factor α-Converting Enzyme (TACE/ADAM-17) Activation in Primary Human Monocytes
    Scott, Alasdair J.
    O'Dea, Kieran P.
    O'Callaghan, David
    Williams, Lynn
    Dokpesi, Justina O.
    Tatton, Louise
    Handy, Jonathan M.
    Hogg, Philip J.
    Takata, Masao
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (41) : 35466 - 35476
  • [42] Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17)
    Qiu, Zheng
    Yan, Ming
    Li, Qian
    Liu, Datao
    Van den Steen, Philippe E.
    Wang, Min
    Opdenakker, Ghislain
    Hu, Jialiang
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (04) : 533 - 540
  • [43] CELLULAR IMMUNE ACTIVITY IN RESPONSE TO INCREASED TRAINING OF THE ELITE ATHLETE
    JAKEMAN, P
    HOPKINS, D
    WARRINGTON, G
    JOURNAL OF PHYSIOLOGY-LONDON, 1993, 473 : P76 - P76
  • [44] Alpha-1 Antitrypsin Augmentation Therapy is Associated with Decreased Neutrophil ADAM-17 Activity, Plasma TNF-α Levels and Normalisation of Neutrophil Apoptosis
    Hurley, K.
    Bergin, D. A.
    Reeves, E. P.
    McElvaney, N. G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : S413 - S414
  • [45] ANGIOTENSIN II INDUCED PROTEOLYTIC CLEAVAGE OF ANGIOTENSIN CONVERTING ENZYME 2 IS MEDIATED VIA THE TNF-ALPHA CONVERTING ENZYME (TACE/ADAM-17): A POSITIVE FEEDBACK MECHANISM IN THE RENIN ANGIOTENSIN SYSTEM
    Patel, V. B.
    Clarke, N. E.
    Wang, Z.
    Putko, B.
    Parajuli, N.
    Lo, J.
    Turner, A. J.
    Oudit, G. Y.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S115 - S115
  • [46] Control of ADAM17 activity by regulation of its cellular localisation (vol 6, 35067, 2016)
    Lorenzen, Inken
    Lokau, Juliane
    Korpys, Yvonne
    Oldefest, Mirja
    Flynn, Charlotte M.
    Kunzel, Ulrike
    Garbers, Christoph
    Freeman, Matthew
    Grotzinger, Joachim
    Dusterhoft, Stefan
    SCIENTIFIC REPORTS, 2016, 6
  • [47] Increased ADAM17 activity is associated with atherosclerosis resistance in LDL-receptor-deficient mice
    Holdt, Lesca M.
    Teupser, Daniel
    Breslow, Jan L.
    Thiery, Joachim
    CIRCULATION, 2007, 116 (16) : 241 - 242
  • [48] Characterization of essential domains in HSD17B13 for cellular localization and enzymatic activity
    Ma, Yanling
    Karki, Suman
    Brown, Philip M.
    Lin, Dennis D.
    Podszun, Maren C.
    Zhou, Wenchang
    Belyaeva, Olga V.
    Kedishvili, Natalia Y.
    Rotman, Yaron
    JOURNAL OF LIPID RESEARCH, 2020, 61 (11) : 1400 - 1409
  • [49] Alpha-1 Antitrypsin Augmentation Therapy Is Associated With Decreased Neutrophil Adam-17 Activity, Decreased Plasma Tnf-Alpha Levels And Normalisation Of Neutrophil Apoptosis
    Hurley, K.
    Bergin, D. A.
    Reeves, E. P.
    McElvaney, N. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [50] Pharmacological hypothesis: Nitric oxide-induced inhibition of ADAM-17 activity as well as vesicle release can in turn prevent the production of soluble endothelin-converting enzyme
    Kuruppu, Sanjaya
    Rajapakse, Niwanthi W.
    Parkington, Helena C.
    Smith, Ian
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2017, 5 (05):